Absci is unlocking the potential of next-generation biologics by harnessing deep learning AI and synthetic biology to explore a vast therapeutic sequence space inaccessible to conventional discovery methods.
Pipeline Therapeutics is focused on developing first-in-class molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair.
Ribbon Biolabs is a synthetic biology company advancing a new technology for the automated synthesis of long DNA molecules to enable innovation in the life sciences.
Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases. Tangible's technology has the potential to be used from consumer contact lens to smart contact lens.
Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. Acquired by Absci
